SVB Leerink Starts Recursion Pharmaceuticals (RXRX) at Outperform
Tweet
Share
E-mailGet Alerts RXRX Hot Sheet
Price: $7.60 --0%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 2
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 2
Join SI Premium – FREE
SVB Leerink initiates coverage on Recursion Pharmaceuticals (NASDAQ: RXRX) with a Outperform rating and a price target of $33.00.
For an analyst ratings summary and ratings history on Recursion Pharmaceuticals click here. For more ratings news on Recursion Pharmaceuticals click here.
Shares of Recursion Pharmaceuticals closed at $23.04 yesterday.
You May Also Be Interested In
- Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'
- BofA Securities Reinstates Gujarat Gas Ltd (GUJGA:IN) at Underperform
- JPMorgan Upgrades Assai Atacadista (ASAI) to Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
